Total EV populations in the plasma of CLL patients not only positively correlate with the advanced stages and overall patient survival but also with the duration of treatment in the initial stages of CLL [203]; these EVs are positive for CD19 and CD37. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.